Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes-Reference-Cited by-同舟云学术

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes

Published:2018-07-20 Issue:1 Volume:12 Page:53-60
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Trimarchi Hernán¹^ORCID,Canzonieri Romina²,Costales-Collaguazo Cristian³,Politei Juan⁴,Stern Anibal²,Paulero Matias¹,González-Hoyos Ivan¹,Schiel Amalia²,Rengel Tatiana¹,Forrester Mariano¹,Lombi Fernando¹,Pomeranz Vanesa¹,Iriarte Romina¹,Muryan Alexis²,Zotta Elsa³

Affiliation:

1. Nephrology Service, Hospital Británico de Buenos Aires, Buenos Aires, Argentina

2. Central Laboratory, Hospital Británico de Buenos Aires, Buenos Aires, Argentina

3. IFIBIO Houssay, CONICET, Physiopathology, Pharmacy and Biochemistry Faculty, Universidad de Buenos Aires, Buenos Aires, Argentina

4. Neurology Department, Laboratorio Neuroquímica Dr Néstor Chamoles Buenos Aires, Buenos Aires, Argentina

Funder

Genzyme

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/12/1/53/27721372/sfy053.pdf

Reference46 articles.

1. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency;Brady;N Engl J Med,1967

2. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN);Fogo;Nephrol Dial Transplant,2010

3. Time to treatment benefit for adult patients with Fabry disease receiving agalsidase beta: data from the Fabry Registry;Ortiz;J Med Genet,2016

4. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications;Weidemann;J Intern Med,2013

5. Podocyturia in Fabry adult untreated and treated patients. A controlled study;Trimarchi;J Nephrol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabry Nephropathy;Amyloidosis and Fabry Disease;2023

2. Enhanced SHP-1 Expression in Podocyturia Is Associated with Kidney Dysfunction in Patients with Diabetes;Kidney360;2022-10-27

3. Brazilian consensus recommendations for the diagnosis, screening, and treatment of individuals with fabry disease: Committee for Rare Diseases - Brazilian Society of Nephrology/2021;Brazilian Journal of Nephrology;2022-06

4. Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease;Journal of Nanobiotechnology;2022-03-09

5. Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies;International Journal of Molecular Sciences;2021-09-18